How American Oncology Network, Inc. stacks up

AONC · against 454 other Healthcare companies listed in US-listed

Growth

86/ 100

Near the top of its peers.

Ranked #104 of 455 · scores higher than 76% of peers

Bars: peers in each 10-point band of the growth score

66 peers with a growth score of 80–89, including AONC · Click a bar to see the companies

Why growth scores 86?

Weighted metrics compared with all Healthcare companies.

Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.

Earnings per share growth is not reported, so it is left out of the score.
faster revenue growth over three years: stronger than 83% of peers. 3-year revenue growth: 23.1% vs peer median 5.8%
faster revenue growth over the last year: stronger than 88% of peers. Revenue growth: 37.5% vs peer median 6.1%

Metric by metric

Position: dot = AONC, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	AONC	Peer median	Better than	Position among peers	Weight
Revenue growthHigher is better · 475 reported	37.5%	11.0%	79%		33%
Earnings per share growthHigher is better · 171 reported	Not reported	21.2%	—	—	33%
3-year revenue growthHigher is better · 433 reported	23.1%	11.0%	70%		33%

A metric that is not reported is left out of the score; the other weights are rescaled.

Ranking by growth score

Top 5 and the companies ranked around AONC

Rank	Company	Market cap	Growth	Overall
1	Phathom Pharmaceuticals, Inc.PHAT · US-listed	464M USD	100	53
2	AnaptysBio, Inc.ANAB · US-listed	1.4B USD	99	73
2	CorMedix Inc.CRMD · US-listed	433M USD	99	81
2	ImmunityBio, Inc.IBRX · US-listed	8.8B USD	99	31
2	Insight Molecular Diagnostics Inc.IMDX · US-listed	90M USD	99	27
⋯
99	Healthcare Services Group, Inc.HCSG · US-listed	1.8B USD	87	80
99	Neurocrine Biosciences, Inc.NBIX · US-listed	16.8B USD	87	75
99	Pharming Group N.V.PHAR · US-listed	915M USD	87	57
99	Qiagen N.V.QGEN · US-listed	10.4B USD	87	70
104	American Oncology Network, Inc.AONC · US-listed	336M USD	86	43
104	HUTCHMED (China) LimitedHCM · US-listed	2.3B USD	86	74
104	Natera, Inc.NTRA · US-listed	56.0B USD	86	39
104	Prime Medicine, Inc.PRME · US-listed	825M USD	86	24
104	Solventum CorporationSOLV · US-listed	14.4B USD	86	71

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…